C. R. Bard
R. Bard, Inc., commonly known as Bard, was a major American medical-device company with roots dating back to 1907. The business developed from an early healthcare-products operation into a global manufacturer of medical, surgical, diagnostic, and patient-care devices. Over its long operating history, Bard became particularly well known for products used in vascular care, urology, oncology, surgery, drainage, biopsy, and other specialized clinical procedures. Before its acquisition, Bard operated internationally and supplied hospitals, physicians, outpatient facilities, long-term care organizations, and other healthcare providers.
Bard’s medical-device portfolio included urinary catheters, vascular-access products, biopsy devices, surgical products, hernia-repair systems, drainage devices, oncology products, and other technologies used in hospitals and clinical environments. Many former Bard product families continue to exist today under the BD organization, including Bardex, PureWick, Lubri-Sil, Magic3, ProFlex, and other established brands. BD continues to provide sales, ordering, technical, customer-service, and product-complaint support for these products.
R. Bard is no longer an independent publicly traded medical-device company. Becton, Dickinson and Company, commonly known as BD, completed its acquisition of Bard on December 29, 2017, after which Bard became a wholly owned subsidiary of BD. Current BD corporate filings continue to list C. R. Bard, Inc. as a New Jersey subsidiary. Therefore, the old Bard headquarters information should not be presented as though Bard still operates as an independent corporation with its own publicly traded headquarters structure.
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
Because C. R. Bard is now a wholly owned subsidiary of BD, BD’s Franklin Lakes headquarters is the appropriate current parent-company headquarters for corporate-level matters. BD’s official contact information continues to identify this address as its headquarters.
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
BD does not currently identify a separate standalone C. R. Bard corporate headquarters for general corporate inquiries. Corporate governance, investor relations, parent-company administration, and high-level corporate communications are handled through BD.
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
For ordinary corporate correspondence involving the Bard business, BD’s current headquarters can be used unless a particular Bard product group provides a specialized shipping, ordering, complaint, or returns address.
BD Urology and Critical Care
8195 Industrial Boulevard
Covington, GA 30014
United States
BD currently identifies this location for several former Bard medical product lines, including Bardex, PureWick, Lubri-Sil, Magic3, and related urology products. It is an operational and customer-service location and should not be confused with BD’s main corporate headquarters.
R. Bard, Inc.
730 Central Avenue
Murray Hill, NJ 07974
United States
This was Bard’s corporate address before the BD acquisition. Historical merger documentation identifies 730 Central Avenue as C. R. Bard’s address, but it should not be presented as the current independent corporate headquarters.
201-847-6800
This is BD’s current verified corporate headquarters number in Franklin Lakes, New Jersey.
1-844-823-5433
BD publishes 1-844-8-BD-LIFE, or 1-844-823-5433, as its main U.S. customer-service and support number. It also supports multiple former Bard product lines.
1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States.
1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States.
customer_support@bd.com
BD publishes this email for general customer-service inquiries. Former Bard product lines may also have product-specific support emails.
Medical technology, medical devices, healthcare products, diagnostic products, surgical devices, urology, vascular care, and patient-care technologies.
C. R. Bard developed into a major medical-device manufacturer before becoming part of BD in 2017.
A separate current employee count for C. R. Bard is no longer publicly reported because Bard operates within BD rather than as an independent publicly traded organization.
BD customer-support hours vary by product group. Its general customer-support resources should be checked for the department involved because individual former Bard product lines can have different service schedules.
Investor Relations: https://investors.bd.com/
Careers: https://jobs.bd.com/
Former Bard urology products include urinary catheters and related drainage and continence-care devices. Product families such as Bardex, Lubri-Sil, Magic3, ProFlex, and related catheter systems continue to receive support through BD.
BD continues to sell several catheter products originating from Bard’s medical portfolio. These include intermittent catheter systems developed for different patient requirements, catheter sizes, materials, tip configurations, and clinical settings.
PureWick products are associated with non-invasive urine-management solutions and are now supported within BD’s broader urology and critical-care portfolio. Customers should use the product-specific BD support channels when they need ordering, troubleshooting, or complaint assistance.
Bard historically developed products for vascular-access procedures and related medical applications. Many technologies and product families from the Bard portfolio were integrated into BD’s broader interventional and vascular-care businesses following the acquisition.
Bard and related businesses developed surgical mesh, fixation, and hernia-repair technologies used by surgeons and healthcare institutions. BD continues to support surgical brands and products through its surgery-related customer-service infrastructure.
Bard developed biopsy instruments and related products designed to assist healthcare professionals in obtaining tissue samples for diagnostic evaluation. These technologies became part of BD’s wider interventional portfolio after the acquisition.
The former Bard organization supplied multiple products used in surgical and perioperative environments, including surgical implants, tissue-repair products, and procedure-specific medical devices.
Bard historically maintained significant operations in oncology and interventional medicine. The acquisition expanded BD’s presence in these areas and added established Bard technologies to BD’s existing medical-device portfolio.
BD provides product information, customer care, ordering assistance, clinical support resources, and complaint-reporting channels for former Bard products. Support requirements differ depending on whether the caller is a patient, healthcare professional, distributor, or institutional customer.
201-847-6800
This is the current verified corporate telephone number for BD, the parent company of C. R. Bard. It connects callers with BD’s Franklin Lakes headquarters.
201-847-6800
This is BD’s main headquarters number at 1 Becton Drive, Franklin Lakes, New Jersey. Corporate matters involving Bard at parent-company level should generally begin here.
201-847-6800
BD publishes this number directly with its headquarters contact information. Bard’s historical Murray Hill number should not be presented as its current independent headquarters number.
201-847-6800
This is the verified BD corporate-office contact. BD does not currently publish a separate general C. R. Bard corporate switchboard for independent corporate matters.
1-844-823-5433
This is BD’s main U.S. customer-service number and supports numerous product groups, including former Bard product families.
1-844-823-5433
Customers who are unsure which former Bard division or product-support team they require can use this number as the principal BD support route.
1-844-823-5433
BD instructs customers to use this number for product complaints and adverse-event reporting. Customers should have the product name, catalog number, lot or serial number, details of the issue, and information about any resulting injury or clinical event available.
1-770-784-6100
BD publishes this ordering number for a group of former Bard urology products, including Bardex, Magic3, PureWick-related product support, and other associated lines.
1-800-531-4124
BD publishes this additional customer-service number for selected surgical brands and product families associated with the Bard and Davol portfolios.
1-800-556-6756
This number is published for ordering and related support involving selected BD surgical products formerly associated with Bard and Davol.
1-800-284-6845
This is BD’s verified Investor Relations number. Bard itself no longer maintains a separate public-company investor-relations operation because it is a BD subsidiary.
1-844-823-5433
BD identifies this number on former Bard product pages for sales inquiries. Specialized sales representatives may handle the inquiry after the caller identifies the appropriate product line.
Because C. R. Bard is now part of BD, callers should generally begin with BD rather than attempting to reach Bard through old standalone-company contact information. For general customer assistance, call 1-844-823-5433 and identify the specific Bard or BD product involved. For corporate-level questions rather than product support, BD’s Franklin Lakes headquarters can be reached at 201-847-6800.
Before calling, prepare the exact product name, catalog or model number, lot or serial number where applicable, healthcare facility information, order number, date of purchase, and description of the issue. If the issue involves a former Bard urology product, telling the representative that it belongs to the Bard urology or critical-care portfolio can help ensure the inquiry is routed to the correct department.
For a product complaint involving injury, malfunction, packaging, sterility, or performance, specifically request the Product Complaint team. BD asks customers to provide the product name, catalog number, lot or serial number, details about what happened, whether a patient or healthcare worker was affected, and whether the affected sample or a photograph is available.
Complaints involving a Bard-branded product may concern a medical-device defect, malfunction, incorrect order, product quality, delivery issue, adverse event, customer service, warranty, billing, or another healthcare-related concern. Because Bard is now part of BD, current complaints should normally be directed through BD. Before contacting the company, collect the product name, catalog number, lot or serial number, purchase information, healthcare-provider records where appropriate, photographs, correspondence, and details of any injury or adverse event.
Begin with BD Customer Service at 1-844-823-5433. Explain that the matter concerns a Bard-branded or former Bard product and provide the exact product information. This helps BD determine whether the case belongs with urology, surgery, interventional medicine, vascular care, or another specialized product group.
Ask to be transferred to the department responsible for the product involved. Former Bard urology products, surgical products, vascular technologies, and other categories may have different specialists, ordering teams, and technical-support channels. Correct routing is especially important for medical-device complaints.
If the first representative cannot resolve the matter, request escalation to a supervisor or product-support manager. Give the representative the existing complaint or case number and explain what action has already been taken and what remains unresolved.
For product complaints and adverse events, BD publishes productcomplaints@bd.com and an online complaint-reporting process. Written reporting is particularly useful when photographs, product identifiers, healthcare documentation, or a detailed chronology need to be included.
If normal product-support channels fail to resolve a corporate-level issue, correspondence can be directed to Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417-1880. Include the complaint reference number and details of previous attempts to obtain assistance.
Medical-device complaints involving a malfunction, injury, adverse event, or potential product-quality issue should be escalated through BD’s Product Complaint and Adverse Event reporting system rather than being treated solely as a general customer-service complaint.
A serious medical-device concern may also be reportable to the U.S. Food and Drug Administration through the appropriate FDA medical-device reporting or MedWatch process. Healthcare professionals and patients should use the regulatory route appropriate to the specific event and product involved.
Billing, purchasing, warranty, or commercial disputes may also qualify for state consumer-protection or contractual dispute channels. Healthcare institutions should review their purchasing agreement, distributor contract, warranty documentation, and BD account records before escalating externally.
If a Bard or BD medical device is alleged to have caused substantial injury, financial loss, or another serious harm, legal rights may depend on product-liability law, contractual provisions, applicable statutes of limitation, and other facts. A qualified attorney can advise whether a formal claim against BD, C. R. Bard, a distributor, healthcare provider, or another party is appropriate.
Ramona Tire is an automotive service company that provides a wide range of tire and…
Car-X Tire & Auto is a well-known automotive service chain in the United States, specializing…
Curo Financial Technologies Corp. is a company that provides a range of financial services, primarily…
Enova International, Inc. is a financial technology (fintech) company that provides online financial services to…
Community Choice Financial Inc. (CCFI) is a financial services company that provides a variety of…
Smile Brands Inc. is a leading provider of business support services to dental practices in…
This website uses cookies.